Clinical trials
Recruiting Phase 1/2 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 2 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 38 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GI Innovation, Inc. | 3 |
| Regeneron Pharmaceuticals | 3 |
| Bristol-Myers Squibb | 2 |
| National Cancer Institute (NCI) | 2 |
| 3D Medicines (Sichuan) Co., Ltd. | 1 |
| 7 Hills Pharma, LLC | 1 |
| A2 Biotherapeutics Inc. | 1 |
| AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | 1 |
| Arvinas Inc. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 38 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Melanoma | 14 |
| Squamous Cell Carcinoma of Head and Neck | 11 |
| Neoplasm Metastasis | 10 |
| Colorectal Neoplasms | 9 |
| Triple Negative Breast Neoplasms | 9 |
| Stomach Neoplasms | 8 |
| Carcinoma, Hepatocellular | 7 |
| Carcinoma, Transitional Cell | 7 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.